Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed May 6, 2021 · 10-Q · 36 days after period end · 0001280776-21-000013
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$34.53M | -$8.49M | -$4.31M | -$2.26M |
| EPS Diluted | -$1.63 | -$0.79 | -$5.09 | -$2.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 6, 2021 · 36 d after period end
